{"id":7130,"date":"2026-02-24T11:50:52","date_gmt":"2026-02-24T16:50:52","guid":{"rendered":"https:\/\/quatuormd.ca\/landropause-un-declin-hormonal-masculin-a-ne-pas-negliger\/"},"modified":"2026-04-28T17:29:46","modified_gmt":"2026-04-28T21:29:46","slug":"landropause-a-decline-hormonal-male-that-should-not-be-overlooked","status":"publish","type":"post","link":"https:\/\/quatuormd.ca\/en\/landropause-a-decline-hormonal-male-that-should-not-be-overlooked\/","title":{"rendered":"Andropause: a decline in male hormones that should not be overlooked"},"content":{"rendered":"\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Menopause in women is a well-recognized public health issue. However, its male equivalent, andropause or age-related androgen deficiency (ARAD), remains largely unknown. Unlike the female transition, andropause does not mark a sudden end to fertility, but rather a gradual decline in testosterone levels, which can profoundly affect men’s vitality and metabolic health from their forties onwards.<\/p>

\u00a0<\/h2>

1. What is andropause?<\/h2>

Andropause corresponds to the decrease in bioavailable testosterone levels associated with aging.<\/p>

  • Hormonal decline: <\/strong>From the age of 40 onwards, total <\/span>testosterone levels decline by an average of 1% per year, while free testosterone (the biologically active fraction) declines by 1.2% per year.<\/p><\/li>

  • A biological reality: <\/strong>According to the European Male <\/span>Aging Study (EMAS), approximately 2.1% of men aged 40 to 79 have symptomatic late-onset hypogonadism, but this rate increases significantly in men with comorbidities such as obesity or diabetes.<\/p><\/li><\/ul>

    \u00a0<\/h2>

    2. The \u201ctherapeutic gap\u201d: telling figures<\/h2>

    Beyond simple clinical observations, research shows a major discrepancy between the prevalence of androgen deficiency and its actual treatment. Andropause remains one of the neglected areas of preventive medicine for men.<\/p>

    The BACH (Boston Area Community Health Survey) study, published in the Journal of Clinical Endocrinology & Metabolism, found that while approximately 24% of men have testosterone deficiency (total or free), only 5% to 10% of those with clear clinical symptoms actually receive treatment.<\/p>

    This \u201ctreatment gap\u201d can be explained by the insidious nature of the symptoms, which are often confused with stress or the simple effects of aging, but also by a persistent taboo that prevents men from talking to their doctors about it.<\/p>

    \u00a0<\/h2>

    3. Symptoms: knowing how to identify them<\/h2>

    Androgen deficiency manifests itself through a set of physical and psychological signs that develop slowly:<\/p>

    \u00a0<\/p>

    The sexual and intimate sphere<\/h4>
    • Decreased libido (sexual desire)<\/li>

    • Erectile dysfunction and reduced frequency of morning erections. <\/span><\/p><\/li><\/ul>

      \u00a0<\/h3>

      The physical and metabolic sphere<\/h4>
      • Sarcopenia:<\/strong> Loss of muscle mass and decrease in physical strength<\/span><\/li>
      • Adiposity:<\/strong> Increase in fat mass, particularly in the abdominal area <\/span><\/li>
      • Fatigue:<\/strong> Persistent lack of energy and sleep disturbances<\/span><\/li>
      • Bone density:<\/strong> Increased risk of male osteoporosis<\/li><\/ul>

        \u00a0<\/h4>

        The psychological sphere<\/h4>
        • Irritability, decreased motivation, and mood disorders: anxiety and depression<\/span>.<\/li>
        • Difficulty concentrating and feeling of \u201cbrain fog.\u201d<\/li><\/ul>

          \u00a0<\/h2>

          4.<\/span>\u00a0Long-term consequences and cardiovascular risks<\/h2>

          Testosterone plays a major protective role in metabolism. A prolonged deficiency is not just a matter of comfort; it is a systemic health issue that promotes insulin resistance and alters the lipid profile, thereby increasing cardiovascular risk (atherosclerosis).<\/p>

          It is estimated that 20% to 30% of cases of male osteoporosis are directly attributable to androgen deficiency.<\/p>

          \u00a0<\/p>

          5. Substitution treatment (ST): a rigorous approach<\/h2>

          This medical therapy requires a precise approach. It is intended for men whose deficiency has been confirmed by repeated blood tests and debilitating clinical symptoms.\u00a0<\/p>

          The benefits of tailored care:<\/strong><\/p>

          • Restoration of libido and sexual function<\/li>
          • Improved body composition (more muscle, less fat)<\/li>
          • Protection of bone capital<\/li>
          • Significant improvement in mood and cognitive abilities<\/span><\/li><\/ul>

            \u00a0<\/p>

            Treatment (in the form of gels, injections, or patches) requires close medical monitoring, including PSA (prostate) and hematocrit monitoring, to ensure optimal safety.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"

            Menopause in women is a well-recognized public health issue. However, its male equivalent, andropause orage-related androgen deficiency (ARAD), remains largely unknown.<\/p>\n","protected":false},"author":5,"featured_media":7161,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_seopress_robots_primary_cat":"none","_seopress_titles_title":"Andropause: a decline in male hormones that should not be overlooked","_seopress_titles_desc":"Menopause in women is a well-recognized public health issue. However, its male equivalent, andropause orage-related androgen deficiency (ARAD), remains largely unknown.","_seopress_robots_index":"","footnotes":""},"categories":[29],"tags":[],"categorie-ressources":[59],"class_list":["post-7130","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-non-classifiee-2","categorie-ressources-maladiesproblemes-de-sante"],"acf":[],"_links":{"self":[{"href":"https:\/\/quatuormd.ca\/en\/wp-json\/wp\/v2\/posts\/7130","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/quatuormd.ca\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/quatuormd.ca\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/quatuormd.ca\/en\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/quatuormd.ca\/en\/wp-json\/wp\/v2\/comments?post=7130"}],"version-history":[{"count":15,"href":"https:\/\/quatuormd.ca\/en\/wp-json\/wp\/v2\/posts\/7130\/revisions"}],"predecessor-version":[{"id":7160,"href":"https:\/\/quatuormd.ca\/en\/wp-json\/wp\/v2\/posts\/7130\/revisions\/7160"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/quatuormd.ca\/en\/wp-json\/wp\/v2\/media\/7161"}],"wp:attachment":[{"href":"https:\/\/quatuormd.ca\/en\/wp-json\/wp\/v2\/media?parent=7130"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/quatuormd.ca\/en\/wp-json\/wp\/v2\/categories?post=7130"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/quatuormd.ca\/en\/wp-json\/wp\/v2\/tags?post=7130"},{"taxonomy":"categorie-ressources","embeddable":true,"href":"https:\/\/quatuormd.ca\/en\/wp-json\/wp\/v2\/categorie-ressources?post=7130"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}